Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Blood Advances
|
April 26, 2024
Defining primary refractory large B-cell lymphoma
Allison M Bock, Raphael Mwangi, Yucai Wang, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk loci
Joseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Leukemia
|
April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
Michelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
American Journal of Hematology
|
March 4, 2021
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma
Matthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Blood Advances
|
April 26, 2024
Defining primary refractory large B-cell lymphoma
Allison M Bock, Raphael Mwangi, Yucai Wang, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk loci
Joseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Leukemia
|
April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
Michelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
American Journal of Hematology
|
March 4, 2021
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma
Matthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Page
of 5